In addition, CLL patients treated with GS-1101 showed a redistribution of CLL cells from the bone marrow and lymphoid organs in the periphery, and a reduction in CCL3 and CCL4 serum levels [49]. The gene discussed is CCL3; the disease is B-cell chronic lymphocytic leukemia.